Quartalszahlen: Evonik steigert operativen Gewinn und betont Eigenständigkeit
Der Chemiekonzern geht gestärkt aus dem dritten Quartal hervor. Finanzchef Rauch wirbt für die Eigenständigkeit des Konzerns – und kritisiert den Zeitpunkt des Übernahmeangebots von BASF.
Düsseldorf – Chemieconcern Evonik released stronger quarterly results, underscoring its independence and growth potential. The company's CFO, Michael Rauch, conveyed in a LinkedIn video message, "Evonik is large enough, Evonik is strong, and we are making Evonik a bit stronger." He emphasized that Evonik can shape its own future and achieve growth independently.
According to the third-quarter figures, Evonik's adjusted operating profit surged by 40% to €629 million, while revenue increased by 13% to €3.8 billion. For the full year, Evonik's outlook is more optimistic, with interim CEO Claus Rettig stating, "We are strong and robust." Analysts had predicted revenues of €3.8 billion and adjusted EBITDA of €633 million.
Special items and cost-cutting measures resulted in a net loss of €53 million, following a loss of €106 million in the previous year. Rettig is actively expanding Evonik and conducting workforce reductions to trim the company's costs.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
